The objective of this report is to summarize the evidence regarding the clinical effectiveness, cost-effectiveness, and guidelines pertaining to the use of melatonin for the treatment of insomnia in adults.
Copyright © 2019 Canadian Agency for Drugs and Technologies in Health.